Rejuve
Rejuve Products are primarily used for
Liver disease
About Rejuve Products
Uses of Rejuve Products
L-Ornithine L-Aspartate is used in the treatment of liver disease.
Rejuve Products side effects
Common
Side Effect of Rejuve is Injection site reactions (pain, swelling, redness).
How Rejuve Products work
L-Ornithine L-Aspartate is a combination of two amino acids which works by protecting the liver from harmful chemical substances (free radicals), thus preventing liver damage.
Patient Concerns about Rejuve Products
Frequently asked questions about Rejuve Products
Frequently asked questions about L-Ornithine L-Aspartate
Q. Is it ok to take alcohol when taking Rejuve Infusion?
No, it is not recommended to take alcohol when on Rejuve Infusion. It is a medicine given in cases of liver failure. Although, there are no reported interaction. Still, in cases of liver failure, alcohol should be avoided as it could worsen your complication of liver disease.
Q. What is Rejuve Infusion?
Rejuve Infusion is made up of two amino acids. It is most commonly used in cases of liver diseases in order to prevent it from abnormal brain function called hepatic encephalopathy.
Q. What is the use of Rejuve Infusion in the treatment of hepatic encephalopathy (HE)?
Hepatic encephalopathy (HE) is a brain disorder which occurs in patients with liver failure. In liver failure, there is increased bacterial growth in the intestine which leads to an accumulation of ammonia in blood. This deteriorating condition of the liver starts affecting the functioning of the brain, causing Hepatic encephalopathy. Rejuve Infusion works by detoxifying the ammonia from the blood, hence decreasing the free ammonia from the body. This, as a result, helps decrease the abnormal functioning of the brain caused due to liver failure.
Q. How is Rejuve Infusion given?
Rejuve Infusion can be given daily as an injection that is injected into the veins. Your doctor will suggest the appropriate dose depending on the patient’s health condition and severity of the disease.